Brainsway Ltd ADR (BWAY) Stock Price, Quote & News

Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitatio...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 2 582 4030

Website: www.brainsway.com

Address:

16 Hartum St, Har Hotzvim, Jerusalem, Israel

KayJ_ May. 4 at 9:01 PM

$TR $AEHL $SPRC $BWAY organization

0 · Reply

Blahblahstock25 Apr. 24 at 7:31 PM

$BWAY https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-sets-new-12-month-high-should-you-buy-2026-04-24/ The literally make a machine that cures depression. This will only go up for the foreseeable future

0 · Reply

moonlife224 Apr. 16 at 7:56 PM

$AEHL $BWAY $SPRC $TR

0 · Reply

AtlasAnalysis Apr. 16 at 1:43 PM

$BWAY another new year high coming?

0 · Reply

OfficialStocktwitsUser Apr. 16 at 12:43 AM

$BWAY RSI: 62.91, MACD: 0.5254 Vol: 0.81, MA20: 13.66, MA50: 12.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

focafoca99 Apr. 13 at 3:39 PM

$BWAY is announcing participation in the Needham Virtual Healthcare Conference on April 15.

0 · Reply

Doozio Apr. 10 at 1:20 AM

$NBIS da huckleberries are going thru da $$$ for this 🧠leader🐑 as da under da radar 💎 $BWAY bust outta $ASND ing bases 🐒🍌🧠⏰♾️

3 · Reply

Doozio Apr. 4 at 6:04 PM

$BWAY even stonk splits won’t stop da 🧠 way back to da east side! 🐒🍌🧠⏰♾️. Powerful 👀

0 · Reply

Bazzzigar Mar. 26 at 7:00 PM

$BWAY BBNX

0 · Reply

DARKP00L Mar. 26 at 11:37 AM

$BWAY 07:37 on Mar. 26 2026 BrainsWay Completes Additional $6M Milestone-Based Convertible Loan To Neurolief #tradeideas

0 · Reply

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

2026-04-28T14:42:00.000Z - 11 days ago

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

2026-04-22T23:10:51.000Z - 16 days ago

BrainsWay Ltd (BWAY) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 68/100

2026-04-17T00:21:58.000Z - 22 days ago

BrainsWay Ltd (BWAY) Shares Fall 3.0% -- GF Value Says Still Overvalued

Wed, 15 Apr 2026 07:30:00 -0400 - 24 days ago

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Mon, 13 Apr 2026 08:00:00 -0400 - 26 days ago

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

2026-04-10T01:34:40.000Z - 4 weeks ago

MEITAV INVESTMENT HOUSE LTD Acquires Significant Stake in BrainsWay Ltd

2026-04-06T17:08:41.000Z - 4 weeks ago

BrainsWay Ltd (BWAY) Stock Price Down 7.22% on Apr 6

2026-04-06T15:13:00.000Z - 4 weeks ago

Zacks.com featured highlights include Cardinal Infrastructure, BrainsWay and Century Aluminum

2026-03-26T12:55:01.000Z - 6 weeks ago

Here's Why Momentum in Brainsway (BWAY) Should Keep going

2026-03-19T13:44:24.000Z - 7 weeks ago

BrainsWay (BWAY) Invests $1M in Axis Integrated Mental Health Venture

2026-03-19T12:00:50.000Z - 7 weeks ago

Brainsway completes revenue-based milestone investment into Axis Integrated

Thu, 19 Mar 2026 07:30:00 -0400 - 7 weeks ago

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

2026-03-12T13:28:54.000Z - 2 months ago

Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday

2026-03-12T12:20:51.000Z - 2 months ago

Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change

2026-03-11T19:01:54.000Z - 2 months ago

BrainsWay Ltd (BRSYF) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances

2026-03-11T18:57:07.000Z - 2 months ago

BrainsWay (BWAY) Soars 10% on Strong Q4 Earnings and Optimistic 2026 Outlook

2026-03-11T18:00:33.000Z - 2 months ago

Q4 2025 Brainsway Ltd Earnings Call Transcript

Wed, 11 Mar 2026 09:18:29 -0400 - 2 months ago

BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates

Mar 11, 2026, 8:30 AM EDT - 2 months ago

BrainsWay Earnings Call Transcript: Q4 2025

2026-03-11T11:38:13.000Z - 2 months ago

Brainsway reports Q4 EPS 7c, consensus 3c

2026-03-11T11:37:56.000Z - 2 months ago

Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M

Wed, 11 Mar 2026 07:30:00 -0400 - 2 months ago

BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

2026-03-11T11:11:16.000Z - 2 months ago

Earnings Scheduled For March 11, 2026

2026-03-10T18:01:41.000Z - 2 months ago

Uncovering Potential: BrainsWay's Earnings Preview

2026-03-10T13:24:16.000Z - 2 months ago

Earnings To Watch: BrainsWay Ltd (BWAY) Reports Q4 2025 Result

Thu, 05 Mar 2026 06:16:08 -0500 - 2 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1

2026-03-04T13:29:03.000Z - 2 months ago

BrainsWay (BWAY) Announces Breakthrough in Depression Treatment

2026-03-04T12:50:32.000Z - 2 months ago

Brainsway announces new data on noninvasive way to treat depression

Wed, 04 Mar 2026 07:30:00 -0500 - 2 months ago

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

2026-03-04T12:30:00.000Z - 2 months ago

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Wed, 25 Feb 2026 08:00:00 -0500 - 2 months ago

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

2026-02-19T19:59:07.000Z - 2 months ago

BrainsWay (BWAY) Invests in Canadian Mental Health Clinics

2026-02-19T12:40:17.000Z - 2 months ago

Brainsway announces new minority-stake investment in BrainStim Health

2026-02-19T12:30:00.000Z - 2 months ago

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

Thu, 19 Feb 2026 07:30:00 -0500 - 2 months ago

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

2026-02-18T14:55:32.000Z - 2 months ago

BrainsWay (BWAY) Gains as Cigna Unit Eases TMS Therapy Access

2026-02-18T12:35:26.000Z - 2 months ago

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

Wed, 18 Feb 2026 07:30:00 -0500 - 2 months ago

BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

2026-02-17T13:56:11.000Z - 2 months ago

BrainsWay (BWAY) Initiates 2-for-1 Forward Split of ADSs

2026-02-17T12:45:55.000Z - 2 months ago

Brainsway announces change in ADS-to-ordinary share ratio

Tue, 17 Feb 2026 07:30:00 -0500 - 2 months ago

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

2026-02-10T20:10:23.000Z - 3 months ago

Brainsway management to meet virtually with Northland

2026-01-26T11:11:37.000Z - 3 months ago

Brainsway price target raised to $30 from $24 at H.C. Wainwright

2026-01-22T14:06:50.000Z - 3 months ago

Brainsway price target raised to $30 from $23 at Northland

2026-01-21T12:41:05.000Z - 3 months ago

Brainsway announces draft coverage policy from Highmark for Deep TMS

Wed, 21 Jan 2026 07:30:00 -0500 - 3 months ago

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

2026-01-12T12:47:01.000Z - 4 months ago

Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system

Mon, 12 Jan 2026 07:30:00 -0500 - 4 months ago

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

2026-01-07T12:51:12.000Z - 4 months ago

BrainsWay (BWAY) Gains Expanded Insurance Coverage for Depression Treatment

2026-01-07T12:37:11.000Z - 4 months ago

Brainsway announces first coverage policy for accelerated Deep TMS

Jan 7, 2026, 7:30 AM EST - 4 months ago

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

2025-12-22T12:35:31.000Z - 4 months ago

Brainsway announces Optum Behavioral expanded policy applicable to Deep TMS

UNH

Dec 22, 2025, 7:30 AM EST - 4 months ago

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

2025-12-08T11:21:38.000Z - 5 months ago

Brainsway price target raised to $24 from $18 at H.C. Wainwright

Nov 25, 2025, 7:30 AM EST - 5 months ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025

2025-11-17T12:46:33.000Z - 6 months ago

Brainsway launches first trial of Deep TMS 360 system for AUD

Nov 17, 2025, 7:30 AM EST - 6 months ago

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

2025-11-13T15:35:16.000Z - 6 months ago

Brainsway price target raised to $18 from $17 at H.C. Wainwright

2025-11-13T11:11:32.000Z - 6 months ago

Brainsway’s Deep TMS device granted FDA clearance in Major Depressive Disorder

Nov 13, 2025, 6:00 AM EST - 6 months ago

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Nov 11, 2025, 7:30 AM EST - 6 months ago

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 4, 2025, 8:00 AM EST - 6 months ago

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

Oct 28, 2025, 8:00 AM EDT - 6 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 27, 2025, 7:30 AM EDT - 6 months ago

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Aug 21, 2025, 7:30 AM EDT - 9 months ago

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

Aug 20, 2025, 7:30 AM EDT - 9 months ago

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

Aug 13, 2025, 7:30 AM EDT - 9 months ago

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Jun 11, 2025, 7:30 AM EDT - 11 months ago

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Jun 10, 2025, 8:00 AM EDT - 11 months ago

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Jun 4, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

May 13, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

Mar 11, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Dec 12, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

Nov 20, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Nov 12, 2024, 7:30 AM EST - 1 year ago

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Oct 29, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

Oct 9, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

Sep 30, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Sep 16, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Announces Significant Expansion on U.S. East Coast

Sep 10, 2024, 8:00 AM EDT - 1 year ago

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

Aug 29, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Appoints Richard A. Bermudes, M.D.

Aug 6, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Jul 23, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 17, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

Jun 10, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Jun 3, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

May 8, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Apr 24, 2024, 8:00 AM EDT - 2 years ago

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease

Mar 18, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems

Mar 6, 2024, 7:30 AM EST - 2 years ago

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Feb 21, 2024, 8:00 AM EST - 2 years ago

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Jan 10, 2024, 7:30 AM EST - 2 years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

KayJ_ May. 4 at 9:01 PM

$TR $AEHL $SPRC $BWAY organization

0 · Reply

Blahblahstock25 Apr. 24 at 7:31 PM

0 · Reply

moonlife224 Apr. 16 at 7:56 PM

$AEHL $BWAY $SPRC $TR

0 · Reply

AtlasAnalysis Apr. 16 at 1:43 PM

$BWAY another new year high coming?

0 · Reply

OfficialStocktwitsUser Apr. 16 at 12:43 AM

0 · Reply

focafoca99 Apr. 13 at 3:39 PM

$BWAY is announcing participation in the Needham Virtual Healthcare Conference on April 15.

0 · Reply

Doozio Apr. 10 at 1:20 AM

$NBIS da huckleberries are going thru da $$$ for this 🧠leader🐑 as da under da radar 💎 $BWAY bust outta $ASND ing bases 🐒🍌🧠⏰♾️

3 · Reply

Doozio Apr. 4 at 6:04 PM

$BWAY even stonk splits won’t stop da 🧠 way back to da east side! 🐒🍌🧠⏰♾️. Powerful 👀

0 · Reply

Bazzzigar Mar. 26 at 7:00 PM

$BWAY BBNX

0 · Reply

DARKP00L Mar. 26 at 11:37 AM

$BWAY 07:37 on Mar. 26 2026 BrainsWay Completes Additional $6M Milestone-Based Convertible Loan To Neurolief #tradeideas

0 · Reply

topstockalerts Mar. 11 at 5:27 PM

$BWAY What’s your upside target here? Momentum continues to favor the bulls 🐂. This trend has legs.

0 · Reply

AStrokeOfLuck Mar. 11 at 5:26 PM

$BWAY didn't know this was a treatment option for some

0 · Reply

mikesterz7 Mar. 11 at 12:31 PM

$BWAY 🚨 Full‑year revenue +27% to $52.2M Q4 adjusted EBITDA +53% to $2.3M Remaining performance obligations +43% to ~$70M 2026 guidance targets revenue $66–68M (27%–30% growth) and adjusted EBITDA $12–14M FDA label expansion and insurer coverage supporting commercial adoption

0 · Reply

topstockalerts Mar. 11 at 12:10 PM

$BWAY Is it going higher? Comment below..

0 · Reply

DonCorleone77 Mar. 11 at 12:05 PM

$BWAY Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M The Company anticipates continued profitability and positive cash flow, targeting operating income of 13% to 14% and Adjusted EBITDA of $12 to $14 million.

0 · Reply

DonCorleone77 Mar. 11 at 12:04 PM

$BWAY Brainsway reports Q4 EPS 7c, consensus 3c Reports Q4 revenue $14.5M, consensus $14.02M. "We successfully closed out 2025 with strong momentum across our business, delivering 27% full-year revenue growth while significantly expanding profitability," said Hadar Levy, Chief Executive Officer of BrainsWay. "Demand for Deep TMS continues to accelerate, supported by expanding customer adoption, additional regulatory clearances, and growing reimbursement coverage. The FDA's recent clearance expanding Deep TMS MDD treatment to adolescents aged 15 to 21, and its clearance of our accelerated Deep TMS MDD protocol, represent meaningful growth catalysts for 2026 and beyond. In addition, our investment in Neurolief has the potential to significantly expand our addressable market and create new growth opportunities."

0 · Reply

StocktwitsEarnings Mar. 11 at 11:38 AM

$BWAY Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.16 up 100.00% YoY • Reported revenue of $14.54M up 27.43% YoY • BrainsWay expects full-year 2026 revenue of $66M to $68M, representing 27% to 30% growth, with operating income targeted at 13% to 14% and Adjusted EBITDA of $12M to $14M.

0 · Reply

resistancebreakers Mar. 11 at 11:37 AM

$BWAY

0 · Reply

Thestocktraderhubzee Mar. 11 at 11:37 AM

$BWAY BrainsWay Q4 EPS $0.04, Inline, Sales $14.545M Beat $14.011M Estimate

0 · Reply

DARKP00L Mar. 11 at 11:32 AM

$BWAY 07:32 on Mar. 11 2026 BrainsWay Sees FY2026 Sales $51.000M-$52.000M vs $64.986M Est #tradeideas

0 · Reply

DARKP00L Mar. 4 at 1:08 PM

$BWAY 07:34 on Mar. 04 2026 BrainsWay New Clinical Data Shows SWIFT Deep TMS Cuts Depression Treatment To 6 Sessions #tradeideas

0 · Reply

Market Cap	668.95M
Revenue (ttm)	52.23M
Net Income (ttm)	7.58M
EPS (ttm)	N/A
PE Ratio	65.64
Forward PE	53.51
Profit Margin	14.51%
Debt to Equity Ratio	0.00

Volume	93,100
Avg Vol	160,914
Day's Range	N/A - N/A
Shares Out	40.03M
Stochastic %K	95%
Beta	1.23
Analysts	Strong Sell
Price Target	$15.33